1.Current status of surgical management of esophageal cancer in China and the future strategy.
You-Sheng MAO ; Jie HE ; Gui-Yu CHENG
Chinese Journal of Oncology 2010;32(6):401-404
China
;
Esophageal Neoplasms
;
pathology
;
surgery
;
Esophagectomy
;
methods
;
trends
;
Esophagoscopy
;
methods
;
Humans
;
Lymph Node Excision
;
methods
;
Survival Rate
3.HIGH LEVEL EXPRESSION AND ACTIVITY DETECTION OF SINGLE CHAIN IMMUNOTOXIN 183B_2ScFvPE38 AGAINST OVARIAN CARCINOMA
Fanglei YOU ; Jie FENG ; Yexia CHENG ; Tianyun FU ; Yu YAO ;
Acta Anatomica Sinica 1953;0(01):-
Objective To prepare the immunotoxin protein (183B 2ScFvPE38) which might be useful in immuno guided therapy for ovarian carcinoma and study the activity of the protein. Methods The methods of ELISA and cytotoxicity were used to study the immunotoxin after induced with IPTG and the activity of the immunotoxin. Results The expressed fusion proteins were detected mostly as inclusion bodies at high level, and soluble immunotoxins were also observed. The results showed liable activity of antibody part and toxic part. Conclusion The recombinant fusion protein 183B 2ScFvPE38 keeps the activity of both components and might be of great use in the future to deal with ovarian carcinoma. [
4.Value of electronic colonoscopy in the diagnosis of childhood chronic diarrhea.
Jie-Yu YOU ; Chan-Bin CHEN ; Wen-Xian OU-YANG
Chinese Journal of Contemporary Pediatrics 2007;9(5):493-494
Adolescent
;
Child
;
Child, Preschool
;
Chronic Disease
;
Colonoscopy
;
methods
;
Diarrhea
;
diagnosis
;
pathology
;
Female
;
Humans
;
Infant
;
Infant, Newborn
;
Male
5.Anorectal motility in children with functional constipation.
Jie-Yu YOU ; Hong-Mei ZHAO ; Wen-Xian OU-YANG
Chinese Journal of Contemporary Pediatrics 2010;12(11):915-917
Adolescent
;
Anal Canal
;
physiopathology
;
Child
;
Constipation
;
physiopathology
;
Female
;
Gastrointestinal Motility
;
physiology
;
Humans
;
Male
;
Rectum
;
physiopathology
6.Coccidioidomycosis in an infant.
Wen-xian OUYANG ; Jie-yu YOU ; Yi-min ZHU
Chinese Journal of Pediatrics 2008;46(12):934-935
Coccidioides
;
Coccidioidomycosis
;
pathology
;
Humans
;
Infant
;
Male
7.Effects of crocetin on VCAM-1 expression in human umbilical vein endothelial cells and monocyte-endothelial cell adhesion.
Shu-guo ZHENG ; Meng-qiu ZHAO ; You-nan REN ; Jie-ren YANG ; Zhi-yu QIAN
Acta Pharmaceutica Sinica 2015;50(1):34-38
Crocetin, a naturally occurring carotenoid, possesses antioxidant and antiatherosclerotic properties, of which the underlying mechanism remains unclear. In the present study, we examined the effects of crocetin (0.1, 1, 10 μmol·L(-1)) on angiotensin II (Ang II, 0.1 μmol·L(-1)) induced expression of vascular cell adhesion molecule-1 (VCAM-1) in human umbilical vein endothelial cells (HUVECs) and monocyte-endothelial cell adhesion. The effects of crocetin on the activation of nuclear factor kappa B (NF-κB) and intracellular reactive oxygen species (ROS) were also observed. The results demonstrated that crocetin notably suppressed Ang II induced NF-κB activation (P<0.01) and VCAM-1 expression (P<0.05, P<0.01) in HUVECs, accompanied by a markedly reduced monocyte-endothelial cell adhesion (P<0.05, P<0.01). In addition, preincubation with crocetin resulted in a significant enhancement of cellular antioxidant capacity (P<0.05, P<0.01), while Ang II induced intracellular ROS decreased markedly (P<0.05, P<0.01). These results indicated that crocetin was capable of suppressing Ang II induced VCAM-1 expression and monocyte-endothelial cell adhesion by suppression of NF-κB activation, which might be derived from the enhancement of antioxidant capacity and subsequent reduction of intracellular ROS.
Angiotensin II
;
metabolism
;
Antioxidants
;
pharmacology
;
Carotenoids
;
pharmacology
;
Cell Adhesion
;
drug effects
;
Human Umbilical Vein Endothelial Cells
;
cytology
;
drug effects
;
metabolism
;
Humans
;
Monocytes
;
cytology
;
NF-kappa B
;
metabolism
;
Reactive Oxygen Species
;
metabolism
;
Vascular Cell Adhesion Molecule-1
;
metabolism
9.Angiographic manifestation and transcatheter arterial embolization of proper esophageal artery in hemoptysis
Sen JIANG ; Xiaohua ZHU ; Xiwen SUN ; Wenxiang ZHI ; Bing JIE ; Zhengqian YOU ; Dong YU ; Gang PENG
Chinese Journal of Radiology 2008;42(6):641-644
Objective To investigate the angiographic manifestation of the proper esophageal artery (PEA),the hish risk factom for the presence of the anomalous PEA in hemoptysis and to evaluate the safety of transcatheter aaefial embolization(TAE) of the PEA using gelatin sponge(GS).Methods Selective esophageal arteriography WSS performed in forty-three patients with hemoptysis,including 15 cases of pulmonary tuberculosis,18 cases of bmnchiectasis,7 cases of posttuberculous bronchiectasis and three cases of lung cancer. One case experienced failure of bronchial arterial embolization. The angiographic manifestation of the PEAs Was studied.The complications of the procedure and clinical results were observed in the patients who underwent TAE using GS.Results Thirty-nine PEAs were catheterized selectively in 37 patients(86.0%).Eighteen anomalous PEAs(46.2%)were catheterized selectively in 17 patients (45.9%).The anomalous PEAs showed tortuosity,dilatation,hyperplasia,shunting with pulmonary artery and anastomosis with the bronchial artery.All lesions involved basal segment of inferior pulmonary lobar. Bronchiectasis Was the most frequent disease for PEA abnormality. No complications occurred and satisfactory curative effect Was achieved with TAE of the anomalous PEAs.Conclusions It is necessary to perform selective proper esophageal arteriography when the lesion involves basal segment of inferior pulmonary lobar in hemoptysis.Supplemental TAE of the anomalous PEA using GS is safe and valuable in the management of hemoptysis.
10.Features and management of very early onset inflammatory bowel disease.
Chinese Journal of Contemporary Pediatrics 2018;20(5):341-345
Inflammatory bowel disease (IBD) is a chronic nonspecific intestinal inflammatory disease of unknown etiology. This disease includes three main types: Crohn′s disease (CD), ulcerative colitis (UC), and IBD-unclassified (IBD-U). IBD is frequently presented in adults, but in recent years, there is a rising incidence in pediatric populations. Very early onset IBD (VEO-IBD) is a fraction of pediatric IBD, but they have exclusive phenotypic and genetic characteristics such that they are accompanied by severe disease course and resistance to conventional therapy. The purpose of this review is to provide a contemporary overview of the clinical features, pathogenesis, and management of VEO-IBD.
Humans
;
Inflammatory Bowel Diseases
;
etiology
;
therapy
;
Nutritional Support
;
Stem Cell Transplantation